StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70−0.00 (-0.00%)

Close on Nov 18, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Curanex Pharmaceuticals's price to book ratio was 33.5× on Nov 11, 2026, against 19.3× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202633.5×+20.4
2025Dec 31, 202513.1×–

More Curanex Pharmaceuticals figures

See a number that looks wrong?